Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shinotoh, H.
Right arrow Articles by Calne, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinotoh, H.
Right arrow Articles by Calne, D. B.

Neurology, Vol 45, Issue 6 1199-1204, Copyright © 1995 by American Academy of Neurology

ARTICLES

MRI and PET studies of manganese-intoxicated monkeys

H Shinotoh, BJ Snow, KA Hewitt, BD Pate, D Doudet, R Nugent, DP Perl, W Olanow and DB Calne
Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, Canada.

Using MRI and PET, we investigated the consequences of manganese intoxication in a primate model of parkinsonism and dystonia. Three rhesus monkeys were injected intravenously with doses of 10 to 14 mg/kg of MnCl2 on seven occasions, each a week apart. Two animals became hypoactive with abnormal extended posturing in the hind limbs. These motor disturbances did not improve with administration of levodopa. In all three monkeys, T1-weighted MRI demonstrated high signal intensities in the regions of the striatum, globus pallidus, and substantia nigra. No significant changes were found on [18F]6-fluoro-L-dopa, [11C]raclopride, or [18F]fluorodeoxyglucose PET. These results are consistent with the pathologic findings, which were primarily confined to the globus pallidus, and indicate that manganese intoxication is associated with preservation of the nigrostriatal dopaminergic pathway, despite clinical evidence of parkinsonian deficits. Chronic manganese intoxication may cause parkinsonism by damaging output pathways downstream to the nigrostriatal dopaminergic pathway. This is consistent with the demonstrated lack of therapeutic response to levodopa.


This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
C.J. da Silva, A.J. da Rocha, S. Jeronymo, M.F. Mendes, F.T. Milani, A.C.M. Maia Jr, F.T. Braga, Y.A.S. Sens, and L.A. Miorin
A Preliminary Study Revealing a New Association in Patients Undergoing Maintenance Hemodialysis: Manganism Symptoms and T1 Hyperintense Changes in the Basal Ganglia
AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1474 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
R. M. A. de Bie, R. M. Gladstone, A. P. Strafella, J.-H. Ko, and A. E. Lang
Manganese-Induced Parkinsonism Associated With Methcathinone (Ephedrone) Abuse
Arch Neurol, June 1, 2007; 64(6): 886 - 889.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
T. R. Guilarte, J. L. McGlothan, M. Degaonkar, M.-K. Chen, P. B. Barker, T. Syversen, and J. S. Schneider
Evidence for Cortical Dysfunction and Widespread Manganese Accumulation in the Nonhuman Primate Brain following Chronic Manganese Exposure: A 1H-MRS and MRI Study
Toxicol. Sci., December 1, 2006; 94(2): 351 - 358.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. H. Reaney, G. Bench, and D. R. Smith
Brain Accumulation and Toxicity of Mn(II) and Mn(III) Exposures
Toxicol. Sci., September 1, 2006; 93(1): 114 - 124.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. A. Josephs, J. E. Ahlskog, K. J. Klos, N. Kumar, R. D. Fealey, M. R. Trenerry, and C. T. Cowl
Neurologic manifestations in welders with pallidal MRI T1 hyperintensity
Neurology, June 28, 2005; 64(12): 2033 - 2039.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
W. C. Koller, K. E. Lyons, and W. Truly
Effect of levodopa treatment for parkinsonism in welders: A double-blind study
Neurology, March 9, 2004; 62(5): 730 - 733.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
C W. Olanow
Manganese-Induced Parkinsonism and Parkinson's Disease
Ann. N.Y. Acad. Sci., March 1, 2004; 1012(1): 209 - 223.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
P. R. Burkhard, J. Delavelle, R. Du Pasquier, and L. Spahr
Chronic Parkinsonism Associated With Cirrhosis: A Distinct Subset of Acquired Hepatocerebral Degeneration
Arch Neurol, April 1, 2003; 60(4): 521 - 528.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. A. Racette, L. McGee-Minnich, S. M. Moerlein, J. W. Mink, T. O. Videen, and J. S. Perlmutter
Welding-related parkinsonism: Clinical features, treatment, and pathophysiology
Neurology, January 9, 2001; 56(1): 8 - 13.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
D. C. Dorman
An Integrative Approach to Neurotoxicology
Toxicol Pathol, January 1, 2000; 28(1): 37 - 42.
[Abstract] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J. L Janavs and M. J Aminoff
Dystonia and chorea in acquired systemic disorders
J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 436 - 445.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.